Investigating how B cells and antibodies in immune system respond to breast cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
King’s College London
New gel technology achieves enhanced brain delivery of a Parkinson’s Disease drug.
A team of researchers from the School of Cancer & Pharmaceutical Sciences at King’s, led by Professor Khuloud Al-Jamal, Head of Medicines Development at the Institute of Pharmaceutical Science, have been working collaboratively with researchers from the University of York to optimise the brain uptake of a new gel designed to treat Parkinson’s Disease.
Parkinson’s Disease is a debilitating and progressive neurodegenerative disease. Over 100,000 people live with the condition in the UK and it’s the fastest growing neurological condition in the world. The main symptoms of the disease are tremor, stiffness, and slowness of movement.